LSL Pharma Group Inc. (TSXV:LSL)

Canada flag Canada · Delayed Price · Currency is CAD
0.3800
-0.0300 (-7.32%)
May 30, 2025, 9:30 AM EDT
-24.00%
Market Cap 47.37M
Revenue (ttm) 17.75M
Net Income (ttm) 3.32M
Shares Out 115.53M
EPS (ttm) 0.03
PE Ratio 13.67
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 42,500
Average Volume 35,750
Open 0.4100
Previous Close 0.4100
Day's Range 0.3800 - 0.4100
52-Week Range 0.2900 - 0.5100
Beta -0.50
RSI 65.51
Earnings Date May 22, 2025

About LSL Pharma Group

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada. [Read more]

Sector Healthcare
CEO Francois Roberge
Employees 114
Stock Exchange TSX Venture Exchange
Ticker Symbol LSL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.